Condition
Implant Site Infection
Total Trials
7
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
14%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Completed3
Unknown2
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT04731025Phase 3Recruiting
Local Antibiotics for Breast Implants
NCT06515886Recruiting
Characterizing the Inflammation Around Dental Implants: Bacterial Infection, Hypersensitivity or Both?
NCT05675241Unknown
Characterizing the Inflammation Around Dental Implants
NCT04787224CompletedPrimary
Vestibular Socket Therapy (VST) in Infected and Non Infected Sockets
NCT03343288Not ApplicableCompletedPrimary
Silver Doped Ceramic Coated Orthopedic Implants
NCT03164408Completed
Orthopaedic Implant Removal
NCT02996929Not ApplicableUnknownPrimary
Safety and Performance of LeadExx LC System in Lead Extraction
Showing all 7 trials